Abbott Laboratories and Novo Nordisk A/S, of Bagsvaerd, Denmark, are partnering, with the goal of integrating insulin dose data from the latter's prefilled and durable connected pens into the digital health tools compatible with the Freestyle Libre system. Integrating these two products through this nonexclusive partnership aims to allow health care professionals, caregivers and diabetics to view glucose and insulin data together to help them make more informed treatment decisions.